Table 3.
Factors related to cerebral endothelial dysfunction in RCVS
| Low BHI (N = 14) | High BHI (N = 14) | P-value | |
|---|---|---|---|
| Age | 46.9 ± 10.93 (30–60) | 52.7 ± 8.55 (35–63) | 0.126 |
| Female sex | 13 (92.9%) | 11 (78.6%) | 0.297 |
| Diabetes mellitus | 2 (14.3%) | 2 (14.3%) | >0.999 |
| Hypertension | 1 (7.1%) | 2 (14.3%) | 0.558 |
| Hyperlipidemia | 5 (35.7%) | 3 (21.4%) | 0.422 |
| Stroke | 0 (0%) | 0 (0%) | |
| Cardiac disease | 1 (7.1%) | 0 (0%) | 0.327 |
| Smoking | 0 (0%) | 1 (7.1%) | 0.327 |
| Current medication | |||
| ARB | 0 (0%) | 1 (7.1%) | 0.276 |
| ACE inhibitor | 1 (7.1%) | 0 (0%) | 0.385 |
| Statin | 2 (14.3%) | 4 (28.6%) | 0.376 |
| History of migraine | 5 (35.7%) | 1 (7.1%) | 0.069 |
| Causes of RCVS | 0.297 | ||
| Idiopathic | 11 (78.6%) | 13 (92.9%) | |
| Postpartum | 3 (21.4%) | 1 (7.1%) | |
| Medication | 0 (0%) | 0 (0%) | |
ACE angiotensin converting enzyme, ARB angiotensin II receptor blocker, RCVS reversible cerebral vasoconstriction syndrome
Values are presented as number (%), mean ± standard deviation (ranges)